Cellestis' tuberculosis diagnostic:
This article was originally published in Clinica
Executive Summary
Melbourne, Australia-based Cellestis has received regulatory approval in South Korea for its tuberculosis (TB) diagnostic, QuantiFERON-TB Gold In-Tube. The test is based on the measurement of IFN-gamma secreted from stimulated T cell lymphocytes previously exposed to Mycobacterium tuberculosis infection. The assay involves an overnight culture of whole blood with tuberculin and control antigens, followed by detection of IFN-gamma in a rapid, single-step, sandwich ELISA. The prevalence of TB in Korea has been reported as 135 per 100,000 people, and BCG vaccination is mandatory. Cellestis will market the test in the Korea via its distributor, Woongbee MeDiTech.